Birgitte Brock
Clinical Associate Professor
Population pharmacokinetics of piperacillin in febrile children receiving cancer chemotherapy: the impact of body weight and target on an optimal dosing regimen
Thorsted, A., Kristoffersson, A. N., Maarbjerg, S. F., Schrøder, H., Wang, M., Brock, Birgitte, Nielsen, E. I. & Friberg, L. E., 2019, In: The Journal of antimicrobial chemotherapy. 74, 10, p. 2984-2993 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The effect of transcutaneous vagus nerve stimulation in patients with polymyalgia rheumatica
Venborg, J., Wegeberg, A. M., Kristensen, S., Brock, Birgitte, Brock, C. & Pfeiffer-Jensen, M., 2021, In: Pharmaceuticals. 14, 11, 1166.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Elevated levels of interleukin-12/23p40 may serve as a potential indicator of dysfunctional heart rate variability in type 2 diabetes
Wegeberg, A. M., Okdahl, T., Riahi, S., Ejskjaer, N., Pociot, Flemming, Størling, Joachim, Brock, Birgitte & Brock, C., 2022, In: Cardiovascular Diabetology. 21, 1, 10 p., 5.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Gastrointestinal function in diabetes is affected regardless of asymptomatic appearance
Wegeberg, A. M., Bertoli, D., Ejskjaer, N., Brock, Birgitte, Drewes, A. M. & Brock, C., 2022, In: Journal of Internal Medicine. 291, 4, p. 505-512 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Subcutaneous adipose tissue composition and function are unaffected by liraglutide-induced weight loss in adults with type 1 diabetes
Wegeberg, A. M., Meldgaard, T., Bæk, A., Drewes, A. M., Vyberg, M., Jessen, N., Brock, Birgitte & Brock, C., 2021, In: Basic and Clinical Pharmacology and Toxicology. 128, 6, p. 773-782 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Cardiac vagal tone as a novel screening tool to recognize asymptomatic cardiovascular autonomic neuropathy: Aspects of utility in type 1 diabetes
Wegeberg, A. M., Lunde, E. D., Riahi, S., Ejskjaer, N., Drewes, A. M., Brock, Birgitte, Pop-Busui, R. & Brock, C., 2020, In: Diabetes Research and Clinical Practice. 170, 108517.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Quantities of comorbidities affects physical, but not mental health related quality of life in type 1 diabetes with confirmed polyneuropathy
Wegeberg, A. L., Meldgaard, T., Hyldahl, S., Jakobsen, P. E., Drewes, A. M., Brock, Birgitte & Brock, C., 2019, In: World Journal of Diabetes. 10, 2, p. 87-95Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Circulating Inflammatory Markers Are Inversely Associated with Heart Rate Variability Measures in Type 1 Diabetes
Wegeberg, A. L., Okdahl, T., Fløyel, T., Brock, C., Ejskjaer, N., Riahi, S., Pociot, Flemming, Størling, Joachim & Brock, Birgitte, 2020, In: Mediators of Inflammation. 2020, 10 p., 3590389.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Liraglutide accelerates colonic transit in people with type 1 diabetes and polyneuropathy: A randomised, double-blind, placebo-controlled trial
Wegeberg, A. L., Hansen, C. S., Farmer, A. D., Karmisholt, J. S., Drewes, A. M., Jakobsen, P. E., Brock, Birgitte & Brock, C., 2020, In: United European Gastroenterology Journal. 8, 6, p. 695-704 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Gastrointestinal symptoms and cardiac vagal tone in type 1 diabetes correlates with gut transit times and motility index
Wegeberg, A. L., Brock, C., Ejskjaer, N., Karmisholt, J. S., Jakobsen, P., Drewes, A. M., Brock, Birgitte & Farmer, A. D., 1 Jan 2021, In: Neurogastroenterology and Motility. 33, 1, 10 p., e13885.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 40108287
Most downloads
-
288
downloads
Blood-Brain Glucose Transfer in Alzheimer's disease: Effect of GLP-1 Analog Treatment
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
230
downloads
In Alzheimer's disease, 6-month treatment with GLP-1 analog prevents decline of brain glucose metabolism: Randomized, placebo-controlled, double-blind clinical trial
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
156
downloads
Oral administration of sitagliptin activates CREB and is neuroprotective in murine model of brain trauma
Research output: Contribution to journal › Journal article › Research › peer-review
Published